Čájehuvvojit 1 - 15 oktiibuot 15 bohtosis ohcui Hesham K. H. Keryakos (22676505)', ohcanáigi: 0,02s
Aiddostahte ozu
-
1
2D–shear-wave elastography example: non-MAFLD CKD case (male, 54 years). Dahkki Zienab M. Saad (22676502)
Almmustuhtton 2025Eará dahkkit: “…Hesham K. H. Keryakos (22676505)…”
-
2
2D–shear-wave elastography example: MAFLD + CKD case (male, 65 years). Dahkki Zienab M. Saad (22676502)
Almmustuhtton 2025Eará dahkkit: “…Hesham K. H. Keryakos (22676505)…”
-
3
eGFR in the study participants. Dahkki Zienab M. Saad (22676502)
Almmustuhtton 2025Eará dahkkit: “…Hesham K. H. Keryakos (22676505)…”
-
4
Demographic and Clinical Characteristics of Study Participants. Dahkki Zienab M. Saad (22676502)
Almmustuhtton 2025Eará dahkkit: “…Hesham K. H. Keryakos (22676505)…”
-
5
Stratification of Liver Stiffness according to eGFR in the MAFLD group. Dahkki Zienab M. Saad (22676502)
Almmustuhtton 2025Eará dahkkit: “…Hesham K. H. Keryakos (22676505)…”
-
6
Medication-inclusive multivariable logistic regression for MAFLD. Dahkki Zienab M. Saad (22676502)
Almmustuhtton 2025Eará dahkkit: “…Hesham K. H. Keryakos (22676505)…”
-
7
Receiver operating characteristic (ROC) curve analysis comparing the performance of non-invasive fibrosis scores in MAFLD patients. Dahkki Zienab M. Saad (22676502)
Almmustuhtton 2025Eará dahkkit: “…Hesham K. H. Keryakos (22676505)…”
-
8
Comparison of Non-invasive Liver Fibrosis Scores. Dahkki Zienab M. Saad (22676502)
Almmustuhtton 2025Eará dahkkit: “…Hesham K. H. Keryakos (22676505)…”
-
9
A. Violin plots showing eGFR distribution in MAFLD (red) vs. non-MAFLD (blue) groups. Dahkki Zienab M. Saad (22676502)
Almmustuhtton 2025Eará dahkkit: “…Hesham K. H. Keryakos (22676505)…”
-
10
Proposed pathophysiological crosstalk between MAFLD and CKD. Dahkki Zienab M. Saad (22676502)
Almmustuhtton 2025Eará dahkkit: “…Hesham K. H. Keryakos (22676505)…”
-
11
Liver Stiffness and Fibrosis Grading by MAFLD Status. Dahkki Zienab M. Saad (22676502)
Almmustuhtton 2025Eará dahkkit: “…Hesham K. H. Keryakos (22676505)…”
-
12
2D–shear-wave elastography example: MAFLD + CKD case (female, 57 years). Dahkki Zienab M. Saad (22676502)
Almmustuhtton 2025Eará dahkkit: “…Hesham K. H. Keryakos (22676505)…”
-
13
Grades of liver fibrosis in MAFLD group (grey) and non-MAFLD group (black). Dahkki Zienab M. Saad (22676502)
Almmustuhtton 2025Eará dahkkit: “…Hesham K. H. Keryakos (22676505)…”
-
14
Multivariable logistic regression models for MAFLD predictors. Dahkki Zienab M. Saad (22676502)
Almmustuhtton 2025Eará dahkkit: “…Hesham K. H. Keryakos (22676505)…”
-
15
Liver Fibrosis Characteristics by CKD Stage in MAFLD Patients (n = 64). Dahkki Zienab M. Saad (22676502)
Almmustuhtton 2025Eará dahkkit: “…Hesham K. H. Keryakos (22676505)…”